Thomas Karn

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 19

Top Topics

Mass Spectrometry

Gene Expression

Neoadjuvant Chemotherapy

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

International journal of molecular sciences

Journal of clinical pathology

NPJ breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Paul Jank, Thomas Karn, Marion T van Mackelenbergh, Judith Lindner, Denise Treue, Jens Huober, Knut Engels, Christine Solbach, Kurt Diebold, Frederic Marmé, Volkmar Mueller, Andreas Schneeweiß, Hans-Peter Sinn, Tanja Fehm, Christian Schem, Elmar Stickeler, Peter Andreas Fasching, Jan Budczies, Bärbel Felder, Valentina Nekljudova, Johannes Holtschmidt, Michael Untch, Carsten Denkert, Sibylle Loibl
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Paul Jank, Thomas Karn, Marion T van Mackelenbergh, Judith Lindner, Denise Treue, Jens Huober, Knut Engels, Christine Solbach, Kurt Diebold, Frederic Marmé, Volkmar Mueller, Andreas Schneeweiß, Hans-Peter Sinn, Tanja Fehm, Christian Schem, Elmar Stickeler, Peter Andreas Fasching, Jan Budczies, Bärbel Felder, Valentina Nekljudova, Johannes Holtschmidt, Michael Untch, Carsten Denkert, Sibylle Loibl
An analysis of PIK3CA hotspot mutations and response to neoadjuvant therapy in breast cancer patients from four prospective clinical trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Peter Andreas Fasching, Christopher W Szeto, Carsten Denkert, Stephen Charles Benz, Karsten E Weber, Patricia Spilman, Jan Budczies, Andreas Schneeweiß, Elmar Stickeler, Sabine Schmatloch, Christian Jackisch, Thomas Karn, Hans-Peter Sinn, Mathias Warm, Marion T van Mackelenbergh, Shahrooz Rabizadeh, Christian Schem, Ernst Heinmöller, Volkmar Mueller, Frederic Marmé, Patrick Soon-Shiong, Valentina Nekljudova, Michael Untch, Sibylle Loibl
Inferred immune-cell activity is an independent predictor of HER2 negative breast cancer prognosis and response to paclitaxel-based therapy in the GeparSepto trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Terence M Williams, Andreas Schneeweiß, Christian Jackisch, Changxian Shen, Karsten E Weber, Peter Andreas Fasching, Carsten Denkert, Jenny Furlanetto, Ernst Heinmöller, Sabine Schmatloch, Thomas Karn, Christopher W Szeto, Marion T van Mackelenbergh, Valentina Nekljudova, Elmar Stickeler, Patrick Soon-Shiong, Christian Schem, Thomas Mairinger, Volkmar Mueller, Frederic Marmé, Michael Untch, Sibylle Loibl
Caveolin gene expression predicts clinical outcomes for early-stage HER2-negative breast cancer treated with paclitaxel-based chemotherapy in the GeparSepto trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Luca Licata, Marco Barreca, Barbara Galbardi, Matteo Dugo, Giulia Viale, Balàzs Győrffy, Thomas Karn, Lajos Pusztai, Luca Gianni, Maurizio Callari, Giampaolo Bianchini
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy. British journal of cancer (2023)
Juliana Pereira Lopes Gonҫalves, Christine Bollwein, Aurelia Noske, Anne Jacob, Paul Jank, Sibylle Loibl, Valentina Nekljudova, Peter Andreas Fasching, Thomas Karn, Frederik Marmé, Volkmar Mueller, Christian Schem, Bruno Valentin Sinn, Elmar Stickeler, Marion van Mackelenbergh, Wolfgang Daniel Schmitt, Carsten Denkert, Wilko Weichert, Kristina Schwamborn
Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging. International journal of molecular sciences 24 (3) (2023)
Juliana Pereira Lopes Gonҫalves, Christine Bollwein, Aurelia Noske, Anne Jacob, Paul Jank, Sibylle Loibl, Valentina Nekljudova, Peter Andreas Fasching, Thomas Karn, Frederik Marmé, Volkmar Mueller, Christian Schem, Bruno Valentin Sinn, Elmar Stickeler, Marion van Mackelenbergh, Wolfgang Daniel Schmitt, Carsten Denkert, Wilko Weichert, Kristina Schwamborn
Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging. International journal of molecular sciences 24 (3) (2023)
Juliana Pereira Lopes Gonҫalves, Christine Bollwein, Aurelia Noske, Anne Jacob, Paul Jank, Sibylle Loibl, Valentina Nekljudova, Peter Andreas Fasching, Thomas Karn, Frederik Marmé, Volkmar Mueller, Christian Schem, Bruno Valentin Sinn, Elmar Stickeler, Marion van Mackelenbergh, Wolfgang Daniel Schmitt, Carsten Denkert, Wilko Weichert, Kristina Schwamborn
Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging. International journal of molecular sciences 24 (3) (2023)
Tao Qing, Thomas Karn, Mariya Rozenblit, Julia Foldi, Michał Marczyk, Naing Lin Shan, Kim R M Blenman, Uwe Holtrich, Kevin M Kalinsky, Funda Meric-Bernstam, Lajos Pusztai
Molecular differences between younger versus older ER-positive and HER2-negative breast cancers. NPJ breast cancer 8 (1) (2022)
Kim R M Blenman, Michał Marczyk, Thomas Karn, Tao Qing, Xiaotong Li, Vignesh Gunasekharan, Vesal Yaghoobi, Yalai Bai, Eiman Y Ibrahim, Tristen Park, Andrea L M Silber, Denise M Wolf, Emily Reisenbichler, Carsten Denkert, Bruno Valentin Sinn, Mariya Rozenblit, Julia Foldi, David L Rimm, Sibylle Loibl, Lajos Pusztai
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Bruno Valentin Sinn, Sibylle Loibl, Claus A Hanusch, Dirk-Michael Zahm, Hans-Peter Sinn, Michael Untch, Karsten Weber, Thomas Karn, Clemens Becker, Frederic Marmé, Wolfgang Daniel Schmitt, Volkmar Müller, Christian Schem, Denise Treue, Elmar Stickeler, Frederik Klauschen, Nicole Burchardi, Jenny Furlanetto, Marion van Mackelenbergh, Peter Andreas Fasching, Andreas Schneeweiß, Carsten Denkert
Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Chiara Massa, Thomas Karn, Carsten Denkert, Andreas Schneeweiss, Claus Hanusch, Jens-Uwe Blohmer, Dirk-Michael Zahm, Christian Jackisch, Marion van Mackelenbergh, Jörg Thomalla, Frederik Marme, Jens Huober, Volkmar Müller, Christian Schem, Anja Mueller, Elmar Stickeler, Katharina Biehl, Peter A Fasching, Michael Untch, Sibylle Loibl, Karsten Weber, Barbara Seliger
Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC. Journal for immunotherapy of cancer 8 (2) (2021)
Thomas Karn, Tobias Meissner, Karsten E Weber, Christine Solbach, Carsten Denkert, Knut Engels, Peter Andreas Fasching, Bruno Valentin Sinn, Iris Schrader, Jan Budczies, Frederic Marmé, Volkmar Müller, Uwe Holtrich, Bernd Gerber, Christian Schem, Brandon M Young, Claus Hanusch, Elmar Stickeler, Jens Huober, Marion van Mackelenbergh, Brian Leyland-Jones, Tanja Fehm, Valentina Nekljudova, Michael Untch, Sibylle Loibl
A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (8) (2020)
Nandini Verma, Yaron Vinik, Ashish Saroha, Nishanth Ulhas Nair, Eytan Ruppin, Gordon B Mills, Thomas Karn, Vinay Dubey, Lohit Khera, Harsha Raj, Flavio Maina, Sima Lev
Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis. Science advances 6 (34) (2020)
Sibylle Loibl, Denise Treue, Jan Budczies, Karsten Weber, Albrecht Stenzinger, Wolfgang Daniel Schmitt, Wilko Weichert, Paul Jank, Jenny Furlanetto, Frederick Klauschen, Thomas Karn, Nicole Pfarr, Gunter von Minckwitz, Markus Möbs, Christian Jackisch, Christine Sers, Andreas Schneeweiss, Peter Andreas Fasching, Christian Schem, Michael Hummel, Marion van Mackelenbergh, Valentina Nekljudova, Michael Untch, Carsten Denkert
Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (13) (2019)
Vikram B Wali, Gauri A Patwardhan, Vasiliki Pelekanou, Thomas Karn, Jian Cao, Alberto Ocana, Qin Yan, Bryce Nelson, Christos Hatzis, Lajos Pusztai
Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer. Scientific reports 9 (1) (2019)
Malgorzata Banys-Paluchowski, Sibylle Loibl, Isabell Witzel, Christoph Mundhenke, Lederer Bianca, Christine Solbach, Thomas Karn, Frederik Marmé, Valentina Nekljudova, Christian Schem, Elmar Stickeler, Nicholas Willumsen, Morten A Karsdal, Michael Untch, Volkmar Müller
Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto Trial. Cancers 11 (8) (2019)
Ahmed El-Balat, Iryna Schmeil, Khayal Gasimli, Nicole Sänger, Thomas Karn, Andre Ahr, Sven Becker, Ruza Arsenic, Uwe Holtrich, Knut Engels
Claudin-1 is linked to presence of implants and micropapillary pattern in serous borderline epithelial tumours of the ovary. Journal of clinical pathology 71 (12) (2018)
Ahmed El-Balat, Ruza Arsenic, Nicole Sänger, Thomas Karn, Sven Becker, Uwe Holtrich, Knut Engels
Fascin-1 expression as stratification marker in borderline epithelial tumours of the ovary. Journal of clinical pathology 69 (2) (2015)